Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 316–330 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5481 DNAH9 Gene Primary Ciliary Dyskinesia Genetic Test (NGS) This test evaluates the DNAH9 gene for mutations associated with primary ciliary dyskinesia (PCD). It identifies variations, including copy number changes and deep intronic variant...	Peripheral Whole Blood, Extracted DNA, or Buccal Swab	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNAH9 gene sequence", "Copy Number Variations (CNVs) in DNAH9", "Deep intronic variants in DNAH9"] Parameters [] Preparation ["Provide detailed clinical history", "Three-generation pedigree recommended"] Indications ["Suspected primary ciliary dyskinesia", "Chronic respiratory infections", "Situs inversus", "Infertility"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: Q34.8, Z15.89, Z14.8 Clinical summary This test evaluates the DNAH9 gene for mutations associated with primary ciliary dyskinesia (PCD). It identifies variations, including copy number changes and deep intronic variants, using Next Generation Sequencing.
TEST-4284 DNAJC19 Gene Dilated Cardiomyopathy with Ataxia Genetic Test This genetic test evaluates the DNAJC19 gene for variants associated with dilated cardiomyopathy and cerebellar ataxia.	Peripheral Whole Blood (EDTA tube)	10–14 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNAJC19 gene variants", "Pathogenic and likely pathogenic variants"] Parameters [] Preparation [] Indications ["Suspected 3-methylglutaconic aciduria type V", "Family history suggestive of 3-methylglutaconic aciduria type V"] Measurement technique Confirm with laboratory Codes LOINC: 94224-6 ICD-10: I42.0, G11.1 Clinical summary This genetic test evaluates the DNAJC19 gene for variants associated with dilated cardiomyopathy and cerebellar ataxia.
TEST-3950 DNM2 Gene Centronuclear Myopathy Type 1 Genetic Test This genetic test identifies pathogenic variants in the DNM2 gene associated with centronuclear myopathy type 1.	Peripheral whole blood or FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DNM2 gene sequence", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Clinical features suggestive of congenital myopathy", "Muscle biopsy showing central nuclei", "Family members of diagnosed individuals"] Measurement technique Confirm with laboratory Codes LOINC: 81307-5 ICD-10: G71.2 Clinical summary This genetic test identifies pathogenic variants in the DNM2 gene associated with centronuclear myopathy type 1.
TEST-3966 DNMT1 Gene Autosomal Recessive Cerebellar Ataxia with Deafness and Narcolepsy Genetic Test This test identifies pathogenic variants in the DNMT1 gene associated with autosomal recessive cerebellar ataxia, deafness, and narcolepsy.	Peripheral whole blood (EDTA), saliva (Oragene), or extracted DNA	3–4 Weeks (Rapid option available upon request)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DNMT1 gene", "Full coding region of the DNMT1 gene (exons and splice sites)"] Parameters [] Preparation ["No fasting required", "No special diet required", "No medication adjustments needed unless instructed by your doctor"] Indications ["Individuals presenting with clinical features of cerebellar ataxia, deafness, and narcolepsy", "Family history of autosomal recessive neurogenetic disorders", "Diagnostic confirmation for clinical management and genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 81226-8 ICD-10: G11.8, H90.3, Z13.79 Clinical summary This test identifies pathogenic variants in the DNMT1 gene associated with autosomal recessive cerebellar ataxia, deafness, and narcolepsy.
TEST-5211 DOK7 Gene Myasthenic Syndrome, Congenital, Type 10 Genetic Test This genetic test evaluates the DOK7 gene for pathogenic variants associated with Congenital Myasthenic Syndrome Type 10 (CMS10).	Whole Blood (4 mL) or Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DOK7 gene", "Point mutations", "Small indels", "Copy number changes"] Parameters [] Preparation ["No fasting required", "No medication adjustment required unless directed by physician"] Indications ["Individuals with symptoms suggesting congenital myasthenic syndrome", "Asymptomatic family members seeking carrier status", "Reproductive planning when one parent carries a DOK7 mutation"] Measurement technique Confirm with laboratory Codes LOINC: 81431-6 ICD-10: G70.2 Clinical summary This genetic test evaluates the DOK7 gene for pathogenic variants associated with Congenital Myasthenic Syndrome Type 10 (CMS10).
TEST-1632 Double Marker Test This test evaluates the risk of Trisomy 21 and Trisomy 18 by measuring specific biomarkers in maternal serum during the first trimester.	Serum (Peripheral Blood)	2–3 days	480.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Free β-human chorionic gonadotropin (β-hCG)", "Pregnancy-associated plasma protein-A (PAPP-A)"] Parameters [{"name": "Free β-hCG", "reference_range": null}, {"name": "PAPP-A", "reference_range": null}] Preparation ["No fasting is required.", "Adequate hydration is recommended."] Indications ["First-trimester prenatal screening for Trisomy 21 and Trisomy 18", "Risk assessment based on maternal age"] Measurement technique Confirm with laboratory Codes LOINC: 45756-8 ICD-10: Z36.1 Clinical summary This test evaluates the risk of Trisomy 21 and Trisomy 18 by measuring specific biomarkers in maternal serum during the first trimester.
TEST-1024 Doxepin Test This diagnostic test evaluates the concentration of doxepin in the patient's serum.	Serum	3–5 Business Days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serum Doxepin Concentration"] Parameters [{"name": "Doxepin", "reference_range": null}] Preparation ["Collect sample 12 hours post-dose for steady-state trough levels", "No specific fasting required"] Indications ["Therapeutic drug monitoring of doxepin", "Assessment of adherence", "Investigation of suspected overdose or toxicity", "Evaluation of potential drug interactions affecting doxepin metabolism"] Measurement technique Confirm with laboratory Codes LOINC: 3396-2 ICD-10: Z51.81 Clinical summary This diagnostic test evaluates the concentration of doxepin in the patient's serum.
TEST-6246 DPYS Gene Dihydropyrimidinuria Genetic Test This genetic test detects pathogenic variants in the DPYS gene associated with dihydropyrimidinuria.	Peripheral Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DPYS gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation [] Indications ["Diagnosis of dihydropyrimidinuria", "Family screening for DPYS gene variants", "Personalized management of suspected metabolic disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21639-8 ICD-10: E79.8 Clinical summary This genetic test detects pathogenic variants in the DPYS gene associated with dihydropyrimidinuria.
TEST-3871 DRD5 Gene ADHD Genetic Test This test analyzes the DRD5 gene for variants associated with ADHD susceptibility and treatment response using Next Generation Sequencing.	Peripheral Whole Blood (Venipuncture or Finger-prick)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DRD5 gene variants", "Single nucleotide variants", "Small insertions/deletions"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation [] Indications ["Suspected ADHD", "Personalized medication selection", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21638-5 ICD-10: F90.9 Clinical summary This test analyzes the DRD5 gene for variants associated with ADHD susceptibility and treatment response using Next Generation Sequencing.
TEST-1012 Drugs of Abuse: 7-Drugs Urine Screen Test This diagnostic test evaluates the presence of seven major classes of drugs of abuse in a urine sample.	Urine	Same-day report (sample by 9 AM)	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Amphetamines", "Barbiturates", "Benzodiazepines", "Cocaine", "Opiates", "Phencyclidine", "Cannabis"] Parameters [] Preparation ["No special preparation is required."] Indications ["Employment screening", "Rehabilitation monitoring", "Forensic purposes", "Clinical assessment of suspected substance abuse"] Measurement technique Confirm with laboratory Codes LOINC: 43157-9 ICD-10: Z13.8 Clinical summary This diagnostic test evaluates the presence of seven major classes of drugs of abuse in a urine sample.
TEST-4552 DSP Gene (Skin Fragility-Woolly Hair Syndrome) Genetic Test This test evaluates the entire DSP gene for mutations associated with skin fragility-woolly hair syndrome and related cardiomyopathy.	Whole Blood / DNA (Peripheral Venipuncture or FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DSP gene sequence", "Mutations (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusion or bone marrow transplant"] Indications ["Suspected skin fragility-woolly hair syndrome", "Family history of the condition", "Unexplained cardiomyopathy"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q84.2, Q82.8 Clinical summary This test evaluates the entire DSP gene for mutations associated with skin fragility-woolly hair syndrome and related cardiomyopathy.
TEST-4838 DSP Gene Keratosis Palmoplantaris Striata Type 2 Genetic Test This genetic test analyzes the DSP gene to detect mutations associated with Keratosis Palmoplantaris Striata Type 2.	Whole Blood, DNA FTA Card, Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DSP gene mutations (SNVs, indels, CNVs)", "Analytical sensitivity"] Parameters [] Preparation [] Indications ["Suspected diagnosis of Keratosis Palmoplantaris Striata Type 2", "Family history of hereditary skin conditions"] Measurement technique Confirm with laboratory Codes LOINC: 79691-4 ICD-10: Q82.8, Z15.89, Z84.81 Clinical summary This genetic test analyzes the DSP gene to detect mutations associated with Keratosis Palmoplantaris Striata Type 2.
TEST-4240 DSP Gene NGS Test for Dilated Cardiomyopathy, Woolly Hair, Keratoderma & Tooth Agenesis This diagnostic test evaluates the entire coding region of the DSP gene for pathogenic variants associated with Carvajal syndrome.	Peripheral whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DSP gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No fasting required", "Provide details of family cardiac events", "Provide names of affected relatives"] Indications ["Diagnosis of Carvajal syndrome", "Family screening for DSP gene variants", "Pre-implantation genetic diagnosis (PGD)", "Cascade testing for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: I42.0, Q84.2, L85.2 Clinical summary This diagnostic test evaluates the entire coding region of the DSP gene for pathogenic variants associated with Carvajal syndrome.
TEST-5261 DSPP Gene Dentin Dysplasia Type 2 Genetic Test This test analyzes the DSPP gene for pathogenic variants associated with hereditary dentin disorders like Dentin Dysplasia Type 2 and Dentinogenesis Imperfecta.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["DSPP gene sequence", "Point mutations", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your physician"] Indications ["Suspected Dentin Dysplasia Type 2", "Suspected Dentinogenesis Imperfecta", "Family history of hereditary dentin disorders", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81335-2 ICD-10: K00.5 Clinical summary This test analyzes the DSPP gene for pathogenic variants associated with hereditary dentin disorders like Dentin Dysplasia Type 2 and Dentinogenesis Imperfecta.
TEST-5220 DSPP Gene Dentinogenesis Imperfecta Shields Type 2 Genetic Test This genetic test identifies pathogenic variants in the DSPP gene, confirming a diagnosis of dentinogenesis imperfecta Shields type 2.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the DSPP gene", "Copy-number variations in the DSPP gene"] Parameters [] Preparation [] Indications ["Suspected diagnosis of dentinogenesis imperfecta Shields type 2", "Differentiation from other dental genetic disorders", "Family risk assessment", "Tailored treatment planning"] Measurement technique Confirm with laboratory Codes LOINC: 93382-9 ICD-10: K00.5, Z13.71, Z15.89 Clinical summary This genetic test identifies pathogenic variants in the DSPP gene, confirming a diagnosis of dentinogenesis imperfecta Shields type 2.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories